These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19422962)

  • 1. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
    Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N; Damico L; Shams N; Lowman H; Kim R
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The impact of locally administrated VEGF inhibitors on vascular homeostasis--controversies concerning safety of intravitreal therapy in AMD patients].
    Machalińska A
    Klin Oczna; 2012; 114(1):63-7. PubMed ID: 22783749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
    Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
    Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related macular degeneration and cardiovascular disease in the era of anti-vascular endothelial growth factor therapies.
    Wong TY
    Am J Ophthalmol; 2009 Sep; 148(3):327-9. PubMed ID: 19703607
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA; Rosenfeld PJ
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic approaches to age-related macular degeneration today.
    Bressler NM
    Ophthalmology; 2009 Oct; 116(10 Suppl):S15-23. PubMed ID: 19800535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S; Tatar O
    Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK
    Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related macular degeneration.
    Brucker AJ
    Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
    Lu X; Sun X
    Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy using the small interfering RNA bevasiranib.
    Singerman L
    Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in the anti-VEGF era.
    Fine HF
    Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
    Hohman TC
    Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G
    Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale for combination therapy in age-related macular degeneration.
    Spaide RF
    Retina; 2009 Jun; 29(6 Suppl):S5-7. PubMed ID: 19553803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.